Concurrent transarterial chemoembolization plus atezolizumab and bevacizumab in unresectable hepatocellular carcinoma: Interim analysis from a multicenter real-world study (CHANCE 023).
Year: 2025
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Rong Yan, Haidong Zhu, Jian Lu, Gao-Jun Teng
Institutions: Zhongda Hospital Southeast University, Southeast University
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4406869449